23andMe Holding Co. (NASDAQ:ME) Insider Kathy L. Hibbs Sells 38,548 Shares

23andMe Holding Co. (NASDAQ:ME) insider Kathy L. Hibbs sold 38,548 shares of 23andMe stock in a transaction that occurred on Thursday, April 18th. The shares were sold at an average price of $0.47, for a total transaction of $18,117.56. Following the completion of the sale, the insider now owns 1,252,315 shares of the company’s stock, valued at approximately $588,588.05. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

23andMe Price Performance

Shares of ME stock traded down $0.02 during trading on Friday, reaching $0.48. The company’s stock had a trading volume of 17,180,838 shares, compared to its average volume of 7,390,713. The company has a market capitalization of $233.20 million, a price-to-earnings ratio of -0.46 and a beta of 1.27. 23andMe Holding Co. has a 1-year low of $0.35 and a 1-year high of $2.21. The stock’s 50-day moving average price is $0.54 and its 200 day moving average price is $0.73.

23andMe (NASDAQ:ME) last announced its quarterly earnings data on Wednesday, February 7th. The company reported ($0.17) earnings per share (EPS) for the quarter. The company had revenue of $44.75 million during the quarter, compared to analyst estimates of $56.30 million. 23andMe had a negative net margin of 210.48% and a negative return on equity of 52.99%.

Hedge Funds Weigh In On 23andMe

Several hedge funds and other institutional investors have recently made changes to their positions in ME. Vanguard Group Inc. increased its holdings in 23andMe by 3.1% in the third quarter. Vanguard Group Inc. now owns 28,145,216 shares of the company’s stock valued at $27,518,000 after buying an additional 834,504 shares during the last quarter. BlackRock Inc. increased its holdings in shares of 23andMe by 4.9% in the 2nd quarter. BlackRock Inc. now owns 19,330,109 shares of the company’s stock valued at $33,828,000 after acquiring an additional 910,127 shares during the last quarter. State Street Corp raised its position in shares of 23andMe by 10.3% during the 2nd quarter. State Street Corp now owns 6,183,243 shares of the company’s stock worth $10,821,000 after acquiring an additional 576,924 shares in the last quarter. Geode Capital Management LLC lifted its stake in 23andMe by 4.7% during the second quarter. Geode Capital Management LLC now owns 5,617,120 shares of the company’s stock worth $9,830,000 after purchasing an additional 254,321 shares during the last quarter. Finally, Voya Investment Management LLC increased its stake in 23andMe by 127.0% in the fourth quarter. Voya Investment Management LLC now owns 5,517,344 shares of the company’s stock valued at $5,040,000 after purchasing an additional 3,086,866 shares during the last quarter. Hedge funds and other institutional investors own 36.10% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Citigroup cut their price objective on 23andMe from $0.85 to $0.47 and set a “neutral” rating on the stock in a report on Tuesday.

About 23andMe

23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.